Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00375245 · ClinicalTrials.gov registry record · Phase 1
Rapamycin With Grapefruit Juice for Advanced Malignancies
A Phase 1 study, sponsored by University of Chicago.
- Completed
- Registry status
- Phase 1
- Development phase
- 41
- Enrollment target
NCT00375245 is a Phase 1 study that has completed, run by University of Chicago. The registered enrollment target is 41 participants.
The verdict
NCT00375245, a Phase 1 study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 41 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.
Interventions
- OTHER Grapefruit Juice
- DRUG Rapamycin (sirolimus)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 41 participants |
| Start Date | 2006-09 |
| Est. Completion | 2012-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00375245
The ClinicalTrials.gov registry entry for NCT00375245 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Grapefruit Juice is the first listed.
NCT00375245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00375245 about?
NCT00375245 is a clinical study titled "Rapamycin With Grapefruit Juice for Advanced Malignancies". The purpose of this study is to determine the highest safe dose of rapamycin when given with a fixed amount of grapefruit juice.
What is the current status of trial NCT00375245?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 41 participants. The study started on 2006-09. Estimated completion is 2012-05.
What interventions are being tested in trial NCT00375245?
The interventions under investigation include: Grapefruit Juice (OTHER), Rapamycin (sirolimus) (DRUG).
Who is sponsoring clinical trial NCT00375245?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.